LEXYAL Hyaluronic Acid Dermal Filler: A Professional Sourcing Guide

LEXYAL is a hyaluronic acid-based dermal filler developed for aesthetic professionals. Sourced from South Korea, it represents a segment of the global HA filler market focused on providing options for clinics and distributors. Understanding the characteristics of such products is essential for professionals selecting inventory for their practice. For a broader range of options, explore our Hyaluronic acid dermal filler catalog.

As the aesthetic market expands, the demand for varied HA filler formulations continues. Professionals often assess products based on their rheological properties, manufacturing processes, and supplier reliability. LEXYAL is positioned within this competitive environment, offering an option for those sourcing Korean-made injectables.

LEXYAL is manufactured by S. Thepharm Co., Ltd., a company based in South Korea. The manufacturer's reputation and adherence to production standards are key considerations for professionals. S. Thepharm operates within the strict regulatory frameworks applicable to medical device manufacturing in South Korea, a country recognized for its contributions to aesthetic technology.

Familiarity with the manufacturing origin helps professionals verify product authenticity and quality standards. Companies like S. Thepharm focus on research and development to maintain their presence in the rapidly evolving aesthetic injectables sector.

LEXYAL products are formulated as hyaluronic acid dermal fillers, designed for professional use. While specific product variants within the LEXYAL line may offer differing viscosities or particle sizes, the core composition remains a stabilized HA gel. Products are typically presented in pre-filled syringes, ready for clinic application. The exact concentration of HA and the cross-linking technology employed are distinguishing factors within the range.

Proper storage and handling protocols are paramount for maintaining product integrity. As with all HA fillers, cold chain maintenance from the point of origin to the clinic is a critical factor for professional supply networks.

South Korea has emerged as a significant hub for the development and manufacturing of hyaluronic acid dermal fillers, exporting to international and regional markets, including LATAM and the GCC. Products like LEXYAL contribute to this market presence, offering alternatives to practitioners globally. The sector's growth is driven by manufacturing advancements and a focus on product diversity.

Clinic owners and aesthetic physicians often compare products based on their market acceptance and the specific needs of their patient demographic. For insights into other options, consider a Dermalax Implant comparison with other leading HA fillers.

For professionals sourcing LEXYAL, wholesale pricing models often include volume-based discounts. The illustrative wholesale price for LEXYAL is $67.0 per unit. This price typically adjusts downwards for larger orders, incentivizing bulk purchases for clinics and distributors. The tiered discount structure allows buyers to optimize their procurement costs.

Illustrative volume tiers are structured as follows:

• 11 units or more: 4% discount
• 21 units or more: 5% discount
• 31 units or more: 6% discount
• 51 units or more: 8% discount

Understanding these structures is vital for inventory management and cost planning. For similar pricing insights on other products, refer to our Lipo Vela Wholesale Price Guide.

Establishing a consistent and reliable supply chain for products like LEXYAL is a strategic priority for aesthetic practices. This involves partnering with distributors who demonstrate transparency in their sourcing and logistics. Ensuring timely delivery, proper storage conditions, and access to product support are all components of an effective professional sourcing strategy.

When stocking HA fillers, professionals may consider a range of products to meet diverse client needs. For example, products like UNIONFILL also offer specific characteristics that might complement a clinic's existing portfolio. Careful consideration of product variety and supply reliability supports clinic operations.